Davidson & Garrard’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $2.85M | Sell |
44,763
-3,720
| -8% | -$237K | 0.67% | 54 |
|
|
2017
Q2 | $2.7M | Sell |
48,483
-2,757
| -5% | -$154K | 0.64% | 56 |
|
|
2017
Q1 | $2.79M | Sell |
51,240
-598
| -1% | -$32.5K | 0.66% | 56 |
|
|
2016
Q4 | $3.03M | Sell |
51,838
-2,410
| -4% | -$141K | 0.75% | 52 |
|
|
2016
Q3 | $2.93M | Buy |
54,248
+7,817
| +17% | +$421K | 0.73% | 51 |
|
|
2016
Q2 | $3.42M | Sell |
46,431
-475
| -1% | -$34.9K | 0.84% | 44 |
|
|
2016
Q1 | $3M | Sell |
46,906
-572
| -1% | -$36.5K | 0.77% | 50 |
|
|
2015
Q4 | $3.27M | Sell |
47,478
-1,135
| -2% | -$78.1K | 0.81% | 45 |
|
|
2015
Q3 | $2.88M | Buy |
48,613
+2,225
| +5% | +$132K | 0.75% | 53 |
|
|
2015
Q2 | $3.09M | Sell |
46,388
-140
| -0.3% | -$9.32K | 0.72% | 52 |
|
|
2015
Q1 | $3M | Sell |
46,528
-869
| -2% | -$56K | 0.68% | 57 |
|
|
2014
Q4 | $2.8M | Sell |
47,397
-1,491
| -3% | -$88K | 0.65% | 59 |
|
|
2014
Q3 | $2.5M | Sell |
48,888
-17,785
| -27% | -$910K | 0.61% | 65 |
|
|
2014
Q2 | $3.23M | Sell |
66,673
-293
| -0.4% | -$14.2K | 0.78% | 50 |
|
|
2014
Q1 | $3.48M | Sell |
66,966
-298
| -0.4% | -$15.5K | 0.87% | 46 |
|
|
2013
Q4 | $3.58M | Sell |
67,264
-1,742
| -3% | -$92.6K | 0.91% | 43 |
|
|
2013
Q3 | $3.19M | Buy |
69,006
+174
| +0.3% | +$8.05K | 0.9% | 45 |
|
|
2013
Q2 | $3.08M | Buy |
+68,832
| New | +$3.08M | 0.92% | 45 |
|